THE HIV RESEARCH TRUST
The Charity supports research into HIV infection in resource limited countries. It provides financefor individual researchers to undertake research, or research training. The support is in theform of scholarships that are awarded by a competitive, peer-reviewed, process for definedprogrammes of work.
Financial health, per its FY2025 accounts
The accounts state that the charity reported an overall deficit of £175,370 for the year, driven by an operational loss and unrealised investment losses, resulting in total funds decreasing to £1,094,989. The trustees consider the financial position to remain strong, noting that reserves fluctuate due to the biennial nature of their principal income source from the HIV Congress. They maintain that maintaining grant commitments in line with anticipated income over a two-year cycle represents a prudent approach.
What the accounts disclose
“Management fee of £56,427 (2024: £50,678) was charged by Terrence Higgins Trust for administration tasks. Intercompany creditors of £10,316 (2024: £109,760) were outstanding at 31 March 2025.” — page 23
“The HIV Glasgow Congress has supported the funds for the charity by donating 50% of surplus income from its bi-annual meeting in Glasgow since the Congress began in 1992.” — page 4
“Management fee of £56,427 (2024: £50,678) was charged by Terrence Higgins Trust for administration tasks. Intercompany creditors of £10,316 (2024: £109,760) were outstanding at 31 March 2025.” — page 23
“The HIV Glasgow Congress has supported the funds for the charity by donating 50% of surplus income from its bi-annual meeting in Glasgow since the Congress began in 1992.” — page 4
Trustees
- Faye Rodney
- PROFESSOR ELIZABETH BUKUSI
- Professor Anton Pozniak
- Professor Catherine Hankins
- Professor Deenan Pillay
- Professor Elizabeth Lucy Corbett
- Professor Euphemia Sibanda
- Richard Angell
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £68k | £185k |
| 31/03/2024 | £135k | £163k |
| 31/03/2023 | £30k | £49k |
| 31/03/2022 | £27k | £108k |
| 31/12/2020 | £129k | £42k |
Common questions
Is THE HIV RESEARCH TRUST financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported an overall deficit of £175,370 for the year, driven by an operational loss and unrealised investment losses, resulting in total funds decreasing to £1,094,989. The trustees consider the financial position to remain strong, noting that reserves fluctuate due to the biennial nature of their principal income source from the HIV Congress. They maintain that maintaining grant commitments in line with anticipated income over a two-year cycle represents a prudent approach. Its FY2025 accounts were audited by HaysMac LLP.